Pyrogen Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Pyrogen Testing Market: By Product & Service (Assays Kits & Reagents, Instruments, Services), By Test Type (LAL Tests, In Vitro Tests, Rabbit Tests), By End-User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Pyrogen Testing Market size is estimated to be valued at USD 1,348.3 Million in 2021 and is poised to grow at a significant CAGR of 12.5% over 2022-2028. Pyrogen testing is essential in modern healthcare since it detects the presence of pyrogen in an organism that causes fever. Pyrogen can be present in lipopolysaccharides and lipoteichoic acid. Contaminated pyrogenic can cause severe harmful consequences in the human body, such as fever. Based on product and service, the pyrogen testing market is segmented into assays, kits & reagents, instruments, and services. The assays, kits, and reagents category held the most significant proportion of the pyrogen testing market. The growing demand for kit-based testing and the frequent need for immunoassays, kits, and reagents in large quantities as opposed to equipment are the primary reasons driving the expansion of this category. Moreover, market players are focusing on launching new products, acquisitions, and collaboration. For instance, Lonza, a multinational manufacturing company for pharmaceutical & biotechnology, Launches the Pyro Cell Monocyte Activation Test System for reliable and sustainable in vitro pyrogen testing. The growing pharmaceutical, biotechnology, and medical devices industries, increased R&D investment, and favorable government policies are some drivers driving the global pyrogen testing market in the forecasting period.

Recent Market Developments:

In April 2021, US-based Associates of Cape Cod, Inc. (ACC), Specializing in chromogenic and turbidimetric reagent technologies, launched its new, innovative product called Pyro Smart NextGen for Bacterial Endotoxin Testing (BET).

Pyrogen Testing Market

MARKET SUMMARY
-
12.5%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.5%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Pyrogen Testing Market

  • The pyrogen testing market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The pyrogen testing market segmented based on product & service, test type, end user and geography.
Key Players
  • Lonza (Switzerland)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Associates of Cape Cod, Inc. (US)
  • GenScript Biotech Corporation (China)
Pyrogen Testing Market Dynamics

The rising frequency of major infectious diseases and epidemics has resulted in a continuous increase in demand for pyrogen testing procedures over the last decade. The market for pyrogen testing techniques (used for endotoxin and microbiological identification) is predicted to rise throughout the forecast period due to infectious diseases worldwide. Endotoxin detection products can help with infectious disease management, especially in places with inadequate healthcare facilities. Moreover, the recent outbreak of the coronavirus disease has created destruction in several nations across the globe.


North-America Got Significant Share

Pyrogen Testing Market

The Pyrogen Testing market in North America is likely to hold the highest revenue share in 2021, and the same trend is expected over the forecast period due to the increased biopharmaceutical and pharmaceutical research spending, growing medication approvals, expanding pharmaceutical drug pipelines, and rising consumer knowledge regarding product safety. the Asia Pacific area is expected to have the most anticipated growth rate during the forecasting period due to rapid growth in emerging countries such as India, China, and Japan.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The pyrogen testing market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Pyrogen Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

Recent key trends affecting the pyrogen testing market are the spread of COVID-19, rising vaccine development focus, and rapid biotechnology and biopharmaceutical industry growth.

The Global Pyrogen Testing Market is anticipated to Witness a CAGR of 12.5% During the Forecast Period of 2022 to 2028.

The key Players Operating in the Global Pyrogen Testing Market are Merck Animal Health, Ceva Sante Animals, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, Elanco, IDEXX, Heska Corporation, Covetous, DRE Veterinary, Mars Inc, Virbac, Televet, Phibro Animal Health Corporation, B. Braun Vet Care.


Report

Company Profile

  • Charles River Laboratories, Inc. (US)
  • Lonza (Switzerland)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Associates of Cape Cod, Inc. (US)
  • GenScript Biotech Corporation (China)
  • bioMérieux SA (France)
  • Eurofins Scientific (Luxembourg)
  • WuXi AppTec (China)
  • Hycult Biotech (Netherlands)

Description

Pyrogen Testing Market size is estimated to be valued at USD 1,348.3 Million in 2021 and is poised to grow at a significant CAGR of 12.5% over 2022-2028. Pyrogen testing is essential in modern healthcare since it detects the presence of pyrogen in an organism that causes fever. Pyrogen can be present in lipopolysaccharides and lipoteichoic acid. Contaminated pyrogenic can cause severe harmful consequences in the human body, such as fever. Based on product and service, the pyrogen testing market is segmented into assays, kits & reagents, instruments, and services. The assays, kits, and reagents category held the most significant proportion of the pyrogen testing market. The growing demand for kit-based testing and the frequent need for immunoassays, kits, and reagents in large quantities as opposed to equipment are the primary reasons driving the expansion of this category. Moreover, market players are focusing on launching new products, acquisitions, and collaboration. For instance, Lonza, a multinational manufacturing company for pharmaceutical & biotechnology, Launches the Pyro Cell Monocyte Activation Test System for reliable and sustainable in vitro pyrogen testing. The growing pharmaceutical, biotechnology, and medical devices industries, increased R&D investment, and favorable government policies are some drivers driving the global pyrogen testing market in the forecasting period.

Recent Market Developments:

In April 2021, US-based Associates of Cape Cod, Inc. (ACC), Specializing in chromogenic and turbidimetric reagent technologies, launched its new, innovative product called Pyro Smart NextGen for Bacterial Endotoxin Testing (BET).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX